Xellera Therapeutics serves as a specialized CDMO for Cell and Gene Therapy (CGT) and Advanced Therapy Products (ATP), delivering comprehensive GMP-compliant manufacturing solutions. The company supports the full development lifecycle—from early-stage process optimization to large-scale commercial production. With advanced facilities, strong regulatory capabilities, and rigorous quality standards, Xellera Therapeutics enables reliable manufacturing and faster commercialization of innovative cell and gene therapies.
| Focus Keyword for your Business/Listing | Cell and Gene Therapy |